Intellia Therapeutics (NTLA) News Today $11.60 +0.18 (+1.58%) Closing price 03:59 PM EasternExtended Trading$11.62 +0.01 (+0.12%) As of 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NTLA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Jump Financial LLC Purchases 141,172 Shares of Intellia Therapeutics, Inc. $NTLAAugust 28 at 6:14 AM | marketbeat.comIntellia Therapeutics (NASDAQ:NTLA) Shares Gap Up After Insider Buying ActivityAugust 27 at 10:52 AM | marketbeat.comCathie Wood’s ARK Investment buys 191.7K shares of Intellia Therapeutics todayAugust 26 at 12:00 AM | msn.comVanguard Group Inc. Acquires 561,978 Shares of Intellia Therapeutics, Inc. $NTLAAugust 26 at 3:04 AM | marketbeat.comCathie Wood’s ARK Investment buys 359K shares of Intellia Therapeutics todayAugust 25 at 11:50 PM | msn.comAptus Capital Advisors LLC Sells 50,196 Shares of Intellia Therapeutics, Inc. $NTLAAugust 24, 2025 | marketbeat.comWilliam Chase Buys 100,000 Shares of Intellia Therapeutics (NASDAQ:NTLA) StockAugust 23, 2025 | insidertrades.comCathie Wood’s ARK Investment buys 150.6K shares of Intellia Therapeutics todayAugust 21, 2025 | msn.comCathie Wood’s ARK Investment buys 560.6K shares of Intellia Therapeutics todayAugust 19, 2025 | msn.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) Given Consensus Recommendation of "Moderate Buy" by BrokeragesAugust 19, 2025 | marketbeat.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Sold by Vestmark Advisory Solutions Inc.August 18, 2025 | marketbeat.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) Receives Average Recommendation of "Moderate Buy" from AnalystsAugust 18, 2025 | americanbankingnews.comIntellia Therapeutics (NASDAQ:NTLA) Shares Gap Up - Time to Buy?August 16, 2025 | marketbeat.comChardan Capital Has Strong Forecast for NTLA FY2025 EarningsAugust 16, 2025 | marketbeat.comIntellia Therapeutics: It May Be Time To Get Excited And Buy (Upgrade)August 15, 2025 | seekingalpha.comChardan Capital Issues Pessimistic Forecast for Intellia Therapeutics (NASDAQ:NTLA) Stock PriceAugust 12, 2025 | marketbeat.comNTLA FY2027 EPS Increased by Brookline Capital ManagementAugust 12, 2025 | marketbeat.comAnalysts Are Upgrading Intellia Therapeutics, Inc. (NASDAQ:NTLA) After Its Latest ResultsAugust 11, 2025 | finance.yahoo.comWedbush Expects Reduced Earnings for Intellia TherapeuticsAugust 11, 2025 | marketbeat.comRoyal Bank Of Canada Issues Pessimistic Forecast for Intellia Therapeutics (NASDAQ:NTLA) Stock PriceAugust 10, 2025 | marketbeat.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2025 Earnings Call TranscriptAugust 9, 2025 | msn.comIntellia Therapeutics (NASDAQ:NTLA) Shares Down 7.3% on Analyst DowngradeAugust 9, 2025 | marketbeat.comIntellia Therapeutics (NASDAQ:NTLA) Price Target Cut to $25.00 by Analysts at HC WainwrightAugust 9, 2025 | marketbeat.comIntellia Therapeutics, Inc. (NTLA) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comIntellia (NTLA) Q2 Revenue Jumps 106%August 7, 2025 | fool.comIntellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company ProgressAugust 7, 2025 | finance.yahoo.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Bought by XTX Topco LtdAugust 7, 2025 | marketbeat.comIntellia Therapeutics Sees IBD RS Rating Rise To 76August 6, 2025 | msn.comIQ EQ FUND MANAGEMENT IRELAND Ltd Grows Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)August 6, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Acquires New Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA)August 4, 2025 | marketbeat.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Purchased by Privium Fund Management B.V.August 3, 2025 | marketbeat.comIntellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)August 1, 2025 | globenewswire.comINTELLIA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Intellia Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmJuly 31, 2025 | globenewswire.comIntellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2025 Earnings and Company UpdatesJuly 31, 2025 | finance.yahoo.comIntellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2025 Earnings and Company UpdatesJuly 31, 2025 | globenewswire.comGSA Capital Partners LLP Raises Stock Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA)July 30, 2025 | marketbeat.comStocks To Watch: Intellia Therapeutics Sees Relative Strength Rating Rise To 80July 28, 2025 | msn.comARK Investment Management LLC Has $92.51 Million Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)July 27, 2025 | marketbeat.comNikko Asset Management Americas Inc. Lowers Stock Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA)July 27, 2025 | marketbeat.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) EVP Sells $104,617.24 in StockJuly 26, 2025 | marketbeat.comIntellia Therapeutics (NASDAQ:NTLA) Trading 6.9% Higher - Time to Buy?July 26, 2025 | marketbeat.comIntellia Therapeutics (NASDAQ:NTLA) Shares Down 7.6% - What's Next?July 25, 2025 | marketbeat.comResearch Analysts Offer Predictions for NTLA Q3 EarningsJuly 21, 2025 | marketbeat.com40,946 Shares in Intellia Therapeutics, Inc. (NASDAQ:NTLA) Purchased by Creekmur Asset Management LLCJuly 19, 2025 | marketbeat.comWith Intellia Therapeutics, Human Patience Beat Hot-Take Trading: Still At 'Buy'July 18, 2025 | seekingalpha.comIntellia Therapeutics (NASDAQ:NTLA) Stock Price Up 5.7% - Here's What HappenedJuly 16, 2025 | marketbeat.comGoldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook (NTLA)Goldman Sachs raised its year-end S&P 500 forecast and identified three stocks that are poised to outperform in the second half of 2025: KSS, NTLA, and GOGO.July 15, 2025 | marketbeat.comNTLA - Intellia Therapeutics Inc Trailing Returns - MorningstarJuly 12, 2025 | morningstar.comMMove Over, Magnificent 7: The Frontier 7 Will Redefine Our FutureJuly 10, 2025 | 247wallst.comIntellia Therapeutics (NASDAQ:NTLA) Stock Price Up 6.1% - Should You Buy?July 8, 2025 | marketbeat.com Get Intellia Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NTLA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NTLA Media Mentions By Week NTLA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTLA News Sentiment▼1.360.99▲Average Medical News Sentiment NTLA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTLA Articles This Week▼913▲NTLA Articles Average Week Get the Latest News and Ratings for NTLA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Intellia Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Beam Therapeutics News CRISPR Therapeutics News Editas Medicine News Twist Bioscience News TG Therapeutics News Cytokinetics News ACADIA Pharmaceuticals News Krystal Biotech News Telix Pharmaceuticals News ADMA Biologics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NTLA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellia Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intellia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access